(Q34442243)

English

Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Bovine herpesvirus 1

object named as

bovine herpesvirus 1

1 reference

based on heuristic

inferred from title

author name string

Bosch JC

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Kaashoek MJ

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

van Oirschot JT

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 October 1997

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1512-1517

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

The DNA of an IPV strain of bovid herpesvirus 1 in sacral ganglia during latency after intravaginal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900092-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Excretion of bovine herpesvirus 1 in semen is detected much longer by PCR than by virus isolation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900092-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Population dynamics of bovine herpesvirus 1 infection in a dairy herd

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900092-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of live and inactivated infectious bovine rhinotracheitis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900092-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900092-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of marker vaccines in eradication of herpesviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900092-3

7 January 2021

based on heuristic

inferred from DOI database lookup

An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900092-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900092-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900092-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900092-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Virulence, immunogenicity and reactivation of seven bovine herpesvirus 1.1 strains: clinical and virological aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900092-3

7 January 2021

based on heuristic

inferred from DOI database lookup

An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900092-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A glycoprotein E deletion mutant of bovine herpesvirus 1 infects the same limited number of tissues in calves as wild-type virus, but for a shorter period

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900092-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(97)00092-3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34442243&oldid=1799847478"